Cambridge study finds blood markers that could help predict, very early in the disease, who will get severe COVID.
Academic rigour, journalistic flair
Articles on Coronavirus insights
Displaying 601 - 620 of 1079 articles
Clear messaging is crucial when dealing with multiple disasters.
The testimonies of bereavement counsellors reveals devastatingly lonely experiences of grief, unexpected feelings of loss and even some silver linings.
Some young people feel their voices and experiences during the pandemic have not been heard.
A virus that is 30% more transmissible is more deadly than a virus that is 30% more deadly. Counter-intuitive but true.
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given could get around this.
History tells us that mass vaccination campaigns are usually messy, while elsewhere, lower-income countries are turning to China, Russia and India for vaccines.
During the first lockdown, the number of people seeking help for depression, anxiety and self-harm dropped by up to 48% in some cases.
In the face of stricter rules, the police and government need to clarify messaging around sanctions
Stay-at-home measures allowed many people to slow down, reflect and invest more time in themselves.
History tells us that delays, administrative hurdles, messiness and complexity are the norm.
We are still only beginning to understand the psychological effects that pandemic restrictions are having on us.
Faced unexpected rises in COVID-19 admissions, computer models can help senior managers plan the use of hospital beds.
So-called ‘variants of concern’ have been cropping up since November.
Using only routinely collected information, this tool can accurately determine whether a COVID patient’s condition is likely to deteriorate.
A ‘psychological vaccine’ has the potential to counter belief in COVID-19 conspiracies.
We should be thinking about airborne transmission of coronavirus.
Prominent ‘danger’ signs are needed online to warn people about misinformation.
With richer countries having bought up most of the leading western vaccines, others are looking to India, China and Russia for supplies.
New variants will push the number needed to reach herd immunity up.
Supported by
Top contributors
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of East Anglia
-
Professor of Public Health, University of Sheffield
-
Lecturer in Psychology, Swansea University
-
Professor in Biomedical Sciences, University of Manchester
-
Professor of Mathematics and Statistics, University of Strathclyde
-
Associate Professor in Viral Immunology, University of Birmingham
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Scientific Officer, University of Leeds
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Assistant Professor of Health Promotion and Policy, UMass Amherst, UMass Amherst
-
Professor of Primary Care Health Sciences, University of Oxford
